Wiktor Doroszuk

Wiktor Doroszuk

Auto-generated profile, based on publicly available information

Wiktor Doroszuk

1st Military Clinical Hospital with Outpatient Clinic SPZOZ in Lublin, Raclawickie Avenue 23, 20-049 Lublin, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2025 in Quality in Sport
Verified
Journal Article
Open access
JUJan Urban
Jan Urban
JNJan Noskowicz
Jan Noskowicz
MPMagdalena Próchnicka
Magdalena Próchnicka
DNDominika Nowak
Dominika Nowak
AZAdam Zarzycki
Adam Zarzycki
WDWiktor Doroszuk
Wiktor Doroszuk
Background: Head injuries remain a prevalent and serious concern in cycling, often resulting in traumatic brain injuries (TBIs) such as concussions and diffuse axonal injuries. Traditional helmets primarily reduce linear forces but are less effective against rotational acceleration, a key factor in TBIs. Objective: This review aims to evaluate the effectiveness of three rotational force mitigation technologies—MIPS (Multi-directional Impact Protection System), WaveCel, and SPIN (Shearing Pad INside)—in preventing TBIs in cyclists. Methods: A literature review was conducted using databases including PubMed and Google Scholar. Search terms included: "head injury", "helmet", "MIPS", "WaveCel", "SPIN", and "concussion prevention". Only peer-reviewed studies published from 2015 onward were included to ensure relevance and up-to-date findings. Key Results: The three systems vary in design and biomechanical performance. MIPS shows consistent reduction in rotational acceleration across various impact conditions. WaveCel demonstrates strong energy absorption capabilities and protection in angled impacts, while SPIN shows promising results in reducing strain on brain tissue. However, direct comparative clinical outcome data remain limited. Conclusions: While all three systems improve protection against rotational forces, current evidence suggests that MIPS and WaveCel offer the greatest potential for reducing TBIs. Further real-world injury data and standardized testing protocols are needed to better assess long-term effectiveness and guide helmet design improvements.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JHJakub Hamouta
Jakub Hamouta
WDWiktor Doroszuk
Wiktor Doroszuk
DSDawid Sewruk
Dawid Sewruk
MPMagdalena Próchnicka
Magdalena Próchnicka
MSMichał Siwek
Michał Siwek
JKJulia Konat
Julia Konat
Background: Gallstone disease (GSD) is a prevalent gastrointestinal disorder, particularly in developed countries, with a global adult prevalence ranging between 10% and 20%. Although often asymptomatic, GSD may lead to serious complications including acute pancreatitis, cholecystitis, and biliary obstruction. Aim: This review aims to summarize current evidence on dietary and lifestyle factors associated with the risk of gallstone disease and explore modifiable risk factors relevant for prevention. Material and Methods: A narrative review of recent literature was conducted using peer-reviewed articles published in PubMed and Google Scholar. Prospective cohort studies, meta-analyses, and Mendelian randomization analyses were included to evaluate associations between dietary patterns, lifestyle behaviors, and gallstone disease risk. Results: High intake of ultra-processed foods, sugar-sweetened beverages, and refined carbohydrates was consistently associated with an increased risk of GSD. Conversely, plant-based diets emphasizing whole and minimally processed foods, high fruit and vegetable consumption, and anti-inflammatory dietary patterns showed protective effects. Vegetarian diets appeared particularly beneficial for women. Additionally, obesity, type 2 diabetes, and smoking were confirmed as causal risk factors, while moderate coffee consumption may reduce GSD risk. Rapid weight loss and weight cycling were also identified as risk enhancers. Additionally, increased physical activity appears to reduce the risk of GSD. Conclusions: The findings highlight the importance of dietary quality and healthy lifestyle choices in the prevention of gallstone disease. Modifiable factors such as diet composition, physical activity, and body weight management play a pivotal role in reducing GSD incidence. Preventive strategies should focus on long-term adherence to plant-based, low-processed diets and healthy lifestyle practices.

30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
JKJulia Konat
Julia Konat
JNJan Noskowicz
Jan Noskowicz
JUJan Urban
Jan Urban
WDWiktor Doroszuk
Wiktor Doroszuk
DSDawid Sewruk
Dawid Sewruk
AFAgnieszka Fitas
Agnieszka Fitas
Background: Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting up to 10% of reproductive-aged women. Beyond reproductive symptoms, PCOS is increasingly associated with mental health challenges, including depression, anxiety, and stress, often overlooked in routine care. Aim: This study assessed the prevalence and severity of psychological symptoms in women with PCOS and identified clinical and behavioral predictors of poor outcomes, with emphasis on modifiable lifestyle factors. Methods: A cross-sectional study was conducted among 200 women aged 18–40 diagnosed with PCOS by Rotterdam criteria. Participants completed the Depression, Anxiety and Stress Scale-21 (DASS-21) and a survey on sleep, physical activity, nutrition, and social support. Clinical indicators included BMI, menstrual regularity, hirsutism, and acne. Pearson correlations and regression models were used to analyze associations. Results: Moderate to severe depression affected 62% of participants, elevated anxiety 54%, and high stress 38%. Higher BMI, irregular cycles, and hirsutism were strongly correlated with worse psychological scores. Protective factors included regular physical activity, sufficient sleep, and positive body image. Regression analyses confirmed both clinical and behavioral predictors were significant (p < 0.05). Conclusions: Women with PCOS experience a substantial psychological burden. Routine care should integrate mental health screening and multidisciplinary management. Lifestyle interventions focusing on exercise, sleep, and body image may significantly improve emotional well-being and overall quality of life.

5 December 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
JBJan Bindas
Jan Bindas
JHJakub Hamouta
Jakub Hamouta
WDWiktor Doroszuk
Wiktor Doroszuk
PDPatrycja Długosz
Patrycja Długosz
MJMarika Jerzak
Marika Jerzak
Background. Marathon running is one of the most popular and rapidly expanding forms of endurance exercise. It provides well-documented cardiovascular, metabolic, and musculoskeletal benefits. Understanding the systemic adaptations and potential health risks associated with long-distance running is essential in sports medicine and physiology. Aim. The aim of this review is to summarize current scientific knowledge on the physiological effects of marathon training and participation, focusing on cardiovascular, metabolic, musculoskeletal, renal, respiratory, and immune responses, as well as training strategies and performance-enhancing methods. Material and Methods. This narrative review is based on a comprehensive literature analysis conducted through PubMed from 2018 to 2024. Keywords used included: "marathon", "endurance running", "cardiovascular remodeling", "exercise physiology". Studies involving both professional and amateur marathon runners were considered. Results. Regular marathon training induces numerous systemic adaptations, including increased VO₂max, improved lipid profile, enhanced musculoskeletal efficiency, and neurohormonal regulation. However, acute and chronic health risks such as arrhythmias, renal stress, respiratory fatigue, and musculoskeletal injuries have also been observed. The degree of physiological strain is strongly correlated with training volume, experience, and recovery strategies. Conclusions. Marathon running, when properly managed, promotes global health and physical performance. However, excessive or inadequately supervised training may lead to adverse effects, particularly in less experienced athletes. Individualized approaches to training, screening, and recovery are essential to maximize benefits and minimize risks.

16 June 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AZAdam Zarzycki
Adam Zarzycki
DNDominika Nowak
Dominika Nowak
MPMagdalena Próchnicka
Magdalena Próchnicka
MSMichał Siwek
Michał Siwek
JHJakub Hamouta
Jakub Hamouta
JUJan Urban
Jan Urban
Endurance running is one of the most popular forms of physical activity, influencing many aspects of health, including lipid metabolism. Regular endurance exercise positively affects the lipid profile, which plays a key role in preventing cardiovascular diseases (CVD). Dyslipidemia, characterized by abnormal levels of cholesterol and triglycerides, is a significant risk factor for the development of these diseases. The purpose of this study is to analyze the impact of endurance running on the lipid profile of amateur and professional athletes, considering the differences in metabolic adaptations resulting from training intensity and lifestyle. A review of the available literature was conducted by searching official databases such as Pubmed and Google Scholar using the following keywords: dyslipidemia, endurance running, cardiovascular, lipoprotein lipase. The results indicate that regular endurance running enhances LPL activity, fatty acid oxidation, and cholesterol transport. Both moderate and high-intensity training lower LDL-C and triglycerides, while raising HDL-C. Lipid responses vary between amateur and professional athletes due to differences in training and lifestyle. Overall, endurance running with a healthy lifestyle effectively improves lipid profiles and reduces cardiovascular risk.

23 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
NSNatalia Strumnik
Natalia Strumnik
BSBartosz Michał Skorupski
Bartosz Michał Skorupski
OSOliwia Sójkowska-Sławińska
Oliwia Sójkowska-Sławińska
ALAnna Leśniewska
Anna Leśniewska
PMPatryk Macuk
Patryk Macuk
WDWiktor Doroszuk
Wiktor Doroszuk
Introduction: Obesity remains one of the most significant global health problems, contributing to increased morbidity, premature mortality, and escalating healthcare expenditures. While lifestyle modification continues to serve as the foundation of therapy, its long-term effects are often modest and difficult to sustain. Bariatric surgery, though highly effective, is invasive and cannot be applied to all patients. For this reason, there is a pressing need for safe and effective pharmacological options. In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as highly promising agents for the treatment of obesity. Materials and Methods: A targeted literature search was conducted in PubMed/MEDLINE and PubMed Central covering studies published from 2012 through 2024. Search terms included”GLP-1 receptor agonists, ”“liraglutide, ”“semaglutide, ”“tirzepatide, ” and”obesity.” Eligible studies were randomized controlled trials (RCTs), systematic reviews, and meta-analyses reporting outcomes related to weight reduction and metabolic parameters. Ten key publications were selected for detailed analysis, encompassing pivotal trials of liraglutide, semaglutide, and tirzepatide. Results: Treatment with liraglutide 3.0 mg daily resulted in average weight reductions of 7–8% over treatment periods ranging from 56 to 104 weeks. Semaglutide 2.4 mg once weekly achieved losses of 14–17% in both adult and adolescent populations. Tirzepatide, a dual GLP-1/GIP receptor agonist, demonstrated unprecedented efficacy, with reductions of up to 20.9% at higher doses. Across all agents, improvements were observed in glycemic control, blood pressure, and lipid metabolism. The most frequently reported adverse events were gastrointestinal, including nausea, vomiting, and diarrhea, typically mild, transient, and dose-dependent. Conclusions: GLP-1RAs represent a paradigm shift in obesity pharmacotherapy, providing substantial and clinically relevant weight loss together with broader cardiometabolic benefits. Nonetheless, weight regain following treatment discontinuation, high financial costs, and the need for long-term safety data remain important challenges. Future research should focus on sustaining treatment effects, evaluating newer incretin-based agents, and improving accessibility in order to maximize their global clinical impact.